Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Peerlinck

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Molecular mechanisms of mild and moderate hemophilia AM Jacquemin, M De Maeyer, R D'Oiron, et al.
British Journal of Haematology|April 1, 1994
Rapid clearance of hepatitis C virus RNA in peripheral blood mononuclear cells of patients with clotting disorders and chronic hepatitis C treated with alpha-2b interferon is not a predictor for sustained response to treatmentK Peerlinck, M Willems, L Sheng, et al.
The Netherlands Journal of Medicine|January 12, 1999
Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and BelgiumE P Mauser-Bunschoten, A de Goede-Bolder, J J Wielenga, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 27, 2017
Measurement of B-domain-deleted ReFacto AF activity with a product-specific standard is affected by choice of reagent and patient-specific factorsM Jacquemin, A Vodolazkaia, J Toelen, et al.
Journal of Thrombosis and Haemostasis : JTH|June 8, 2011
Successful immune tolerance induction by FVIII in hemophilia A patients with inhibitor may occur without deletion of FVIII-specific T cellsB Pautard, R D'Oiron, V Li Thiao Te, et al.
Journal of Medical Virology|March 1, 1994
Hepatitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: evidence for viral replication in peripheral blood mononuclear cellsM Willems, K Peerlinck, H Moshage, et al.
Alimentary Pharmacology & Therapeutics|March 12, 2008
Review article: blood platelet number and function in chronic liver disease and cirrhosisP Witters, K Freson, C Verslype, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2010
Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpuraH B Feys, N Vandeputte, R Palla, et al.
International Journal of Laboratory Hematology|March 21, 2017
The amplitude of coagulation curves from thrombin time tests allows dysfibrinogenemia caused by the common mutation FGG-Arg301 to be distinguished from hypofibrinogenemiaM Jacquemin, I Vanlinthout, I Van Horenbeeck, et al.
Thrombosis and Haemostasis|February 12, 1998
Dominant C2 domain epitope specificity of inhibitor antibodies elicited by a heat pasteurized product, factor VIII CPS-P, in previously treated hemophilia A patients without inhibitorsY Sawamoto, R Prescott, D Zhong, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Molecular mechanisms of mild and moderate hemophilia AM Jacquemin, M De Maeyer, R D'Oiron, et al.
British Journal of Haematology|April 1, 1994
Rapid clearance of hepatitis C virus RNA in peripheral blood mononuclear cells of patients with clotting disorders and chronic hepatitis C treated with alpha-2b interferon is not a predictor for sustained response to treatmentK Peerlinck, M Willems, L Sheng, et al.
The Netherlands Journal of Medicine|January 12, 1999
Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and BelgiumE P Mauser-Bunschoten, A de Goede-Bolder, J J Wielenga, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 27, 2017
Measurement of B-domain-deleted ReFacto AF activity with a product-specific standard is affected by choice of reagent and patient-specific factorsM Jacquemin, A Vodolazkaia, J Toelen, et al.
Journal of Thrombosis and Haemostasis : JTH|June 8, 2011
Successful immune tolerance induction by FVIII in hemophilia A patients with inhibitor may occur without deletion of FVIII-specific T cellsB Pautard, R D'Oiron, V Li Thiao Te, et al.
Journal of Medical Virology|March 1, 1994
Hepatitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: evidence for viral replication in peripheral blood mononuclear cellsM Willems, K Peerlinck, H Moshage, et al.
Alimentary Pharmacology & Therapeutics|March 12, 2008
Review article: blood platelet number and function in chronic liver disease and cirrhosisP Witters, K Freson, C Verslype, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2010
Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpuraH B Feys, N Vandeputte, R Palla, et al.
International Journal of Laboratory Hematology|March 21, 2017
The amplitude of coagulation curves from thrombin time tests allows dysfibrinogenemia caused by the common mutation FGG-Arg301 to be distinguished from hypofibrinogenemiaM Jacquemin, I Vanlinthout, I Van Horenbeeck, et al.
Thrombosis and Haemostasis|February 12, 1998
Dominant C2 domain epitope specificity of inhibitor antibodies elicited by a heat pasteurized product, factor VIII CPS-P, in previously treated hemophilia A patients without inhibitorsY Sawamoto, R Prescott, D Zhong, et al.
Pageof 9